GLP-1 plus muscle preservation.

semaglutide or tirzepatide with a GH secretagogue

A real problem, a popular peptide answer, and an evidence base that points somewhere else entirely.

Evidence check · reviewed June 1, 2026

What is in it
Semaglutide
S tierFDA-approved
Tirzepatide
S tierFDA-approved
Ipamorelin
F tierResearch / preclinical
CJC-1295
F tierResearch / preclinical
IGF-1 LR3
F tierResearch / preclinical
The claim

Because a portion of the weight lost on GLP-1 drugs is lean mass, adding a growth hormone secretagogue or an IGF-1 analog is said to preserve muscle during the weight-loss phase.

What the evidence actually shows.

The problem being solved is genuine, and unusually well documented for this field. Across the large GLP-1 trials, roughly a quarter to a third of the weight lost is lean body mass. That figure is broadly what happens with caloric restriction by any method rather than something unique to these drugs, but it is real and it matters, particularly for older people and anyone already close to a functional threshold.

What the evidence supports as the answer is not a peptide. Resistance training and adequate protein intake are the interventions with actual trial support for preserving lean mass during weight loss, and that support is reasonably strong. The exercise-plus-GLP-1 studies show preferential preservation of lean mass, which is the outcome the peptide additions claim to deliver.

For the peptide additions themselves, no controlled trial has tested a GH secretagogue or an IGF-1 analog alongside a GLP-1 drug for lean mass preservation. The rationale is mechanistic: growth hormone influences body composition, so raising it during a deficit should help. That reasoning is plausible and untested in this specific context, which is exactly the pattern this site keeps finding.

There is also a metabolic tension worth naming. Growth hormone is counter-regulatory to insulin and can worsen insulin sensitivity, while the entire point of the GLP-1 drug is improving glycemic control. Combining them is not obviously additive in the direction people assume, and nobody has measured what actually happens.

The honest verdict

The lean-mass concern is real and well documented. The evidence-backed response is resistance training and adequate protein, not a peptide addition. No trial has tested these combinations, and the metabolic interaction runs in an unhelpful direction.

FAQ.

How much muscle do you actually lose on a GLP-1?

Roughly a quarter to a third of total weight lost is lean mass in the trials, which is comparable to caloric restriction by other means rather than unique to these drugs.

What actually preserves lean mass?

Resistance training and adequate protein intake are the interventions with real trial support, and the exercise-plus-GLP-1 studies show preferential lean-mass preservation.

Is combining a GH secretagogue with a GLP-1 safe?

It has not been studied. Beyond the general absence of data, growth hormone is counter-regulatory to insulin, so the combination works against the glycemic benefit rather than with it.

Cite this page

PepCue. “GLP-1 plus muscle preservation stacks: what actually works.” PepCue, reviewed June 1, 2026. https://www.pepcue.app/stacks/glp1-muscle-preservation.

Other stacks
The Wolverine stackThe GLOW stackThe KLOW stackThe GH stackThe nootropic stackSermorelin plus a GHRP
Compounds